PATENT CLAIM ANALYSIS

Application Number: 16083865
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "637000"]

Abstract:
An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.

Claim (Index 6):
The composition of  claim 3 , wherein the copper-containing agent is a member selected from the group consisting of copper sulfate, copper carbonate, copper acetate, copper chloride, copper gluconate, copper bromide, copper fluoride, copper nitrate, copper iodide, copper perchlorate, copper molybdate, copper thiocyanate, copper tartrate, copper tetrafluoroborates, copper selenide, copper pyrophosphate, GHK-copper, tetra-amine copper sulfate, copper-histidine, copper-glycinate, and combinations thereof.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.57143
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13665495', '13387668', '13480127', '15570016', '12315829']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7453293556050086
- 35 USC 102 Novelty (BERT): 0.5030636077844589
- Combined Prediction Score: 0.7211027808229535
- Mean Citation Score: 180.467596
- Max Citation Score: 190.64987
- Similarity Product: 109.08288977084756

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test